Ayala Pharmaceuticals Inc (ADXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADXS | ATNM | NNVC | ||
| Company | Ayala Pharmaceuticals Inc | Actinium Pharmaceuticals Inc | Nanoviricides Inc | ||
| Price Information | |||||
| Exchange | OTC US | NYSE Arca | NYSE Arca | ||
| Open | 0.6195 | 1.3100 | 1.3000 | ||
| High | 0.6195 | 1.3300 | 1.3072 | ||
| Low | 0.6000 | 1.2500 | 1.2301 | ||
| Latest | 0.6036 | 1.2800 | 1.2600 | ||
| Change | +0.0336 | -0.0300 | -0.0400 | ||
| % Change | +5.89% | -2.29% | -3.08% | ||
| Volume | 13,500 | 177,100 | 179,500 | ||
| 20-Day Average Volume | 12,970 | 298,060 | 227,220 | ||
| Previous Close | 0.5700 | 1.3100 | 1.3000 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2959 | 1.1803 | 1.1013 | ||
| 20-Day Raw Stochastic | 86.21% | 56.81% | 62.90% | ||
| 20-Day Relative Strength | 64.81 | 54.34 | 57.87 | ||
| Weighted Alpha | +228.41 | -7.27 | -29.70 | ||
| Today's Opinion | 100% Buy | 24% Sell | 8% Buy | ||
| Previous Opinion | 100% Buy | 24% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Buy | 100% Sell | 96% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.01% since 01/23/26 | -1.54% since 04/17/26 | -8.03% since 04/17/26 | ||
| Low | 0.3333 on 01/28/26 | 1.2500 on 04/24/26 | 1.2000 on 04/21/26 | ||
| High | 0.7000 on 01/29/26 | 1.5294 on 04/21/26 | 1.4900 on 04/20/26 | ||
| 1-Month | |||||
| %Chg | +663.08% since 01/02/26 | +19.63% since 03/24/26 | +32.63% since 03/24/26 | ||
| Low | 0.0011 on 01/06/26 | 0.9520 on 03/31/26 | 0.8700 on 03/30/26 | ||
| High | 0.7000 on 01/29/26 | 1.5294 on 04/21/26 | 1.4900 on 04/20/26 | ||
| 3-Month | |||||
| %Chg | +1,081.21% since 11/03/25 | -1.54% since 01/23/26 | +9.57% since 01/23/26 | ||
| Low | 0.0011 on 01/06/26 | 0.9520 on 03/31/26 | 0.8500 on 02/05/26 | ||
| High | 0.7000 on 01/29/26 | 1.5294 on 04/21/26 | 1.4900 on 04/20/26 | ||
| 6-Month | |||||
| %Chg | +1,405.24% since 07/28/25 | -23.35% since 10/24/25 | -17.65% since 10/24/25 | ||
| Low | 0.0011 on 01/06/26 | 0.9520 on 03/31/26 | 0.8500 on 02/05/26 | ||
| High | 0.8010 on 08/25/25 | 1.7200 on 12/22/25 | 2.2299 on 11/05/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 35,797 | 40,160 | 27,210 | ||
| Shares Outstanding, K | 59,305 | 31,375 | 21,595 | ||
| Annual Sales | 10,000 | 90,000 | 0 | ||
| Annual Net Income | -48,070,000 | -33,890,000 | -9,470,000 | ||
| Last Quarter Sales | 0 | 90,000 | 0 | ||
| Last Quarter Net Income | -7,340,000 | -5,130,000 | -2,220,000 | ||
| 60-Month Beta | 1.75 | -0.21 | 1.30 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A on 09/10/21 | -0.19 on 03/30/26 | -0.11 on 02/17/26 | ||
| Latest Earnings Date | 02/19/24 | 05/08/26 | 05/21/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||